Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults.
Coronavirus Literature
Publication date: Feb 05, 2025 Concepts Keywords 3rd Adjuvant Driving Advax-CpG Nct05542862 COVID-19 Nuclear Delta inulin Vaccine Pandemic SARS-CoV-2 Vaccine Semantics Type Source Name disease IDO protein disease MESH breakthrough ... Read more